Carrera Capital Advisors Raises Stock Holdings in The Clorox Company (NYSE:CLX)

Key Points

• Carrera Capital Advisors increased its holdings in The Clorox Company by 15.9% in Q1, owning 20,365 shares valued at approximately $2,999,000.
• Several institutional investors, including Ridgewood Investments and LPL Financial, have significantly raised their positions in Clorox recently, increasing overall institutional ownership to 78.53%.
• Clorox's recent earnings report showed an EPS of $1.45, missing analysts' expectations, with revenue down 8.0% year-over-year.

Carrera Capital Advisors lifted its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 15.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,365 shares of the company's stock after purchasing an additional 2,795 shares during the quarter. Carrera Capital Advisors' holdings in Clorox were worth $2,999,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Ridgewood Investments LLC lifted its position in Clorox by 194.1% in the 1st quarter. Ridgewood Investments LLC now owns 2,250 shares of the company's stock worth $331,000 after buying an additional 1,485 shares during the last quarter. LPL Financial LLC lifted its position in Clorox by 12.7% in the 1st quarter. LPL Financial LLC now owns 334,041 shares of the company's stock worth $49,188,000 after buying an additional 37,538 shares during the last quarter. Texas Yale Capital Corp. lifted its position in Clorox by 11.8% in the 1st quarter. Texas Yale Capital Corp. now owns 14,244 shares of the company's stock worth $2,097,000 after buying an additional 1,509 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Clorox by 4.1% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 155,767 shares of the company's stock worth $22,937,000 after buying an additional 6,105 shares during the last quarter. Finally, Empirical Finance LLC lifted its position in Clorox by 3.8% in the 1st quarter. Empirical Finance LLC now owns 4,385 shares of the company's stock worth $646,000 after buying an additional 159 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Analyst Ratings Changes

Several brokerages have weighed in on CLX. Evercore ISI set a $140.00 price objective on Clorox and gave the company an "underperform" rating in a research report on Tuesday, May 6th. Wells Fargo & Company lowered their price objective on Clorox from $142.00 to $135.00 and set an "equal weight" rating for the company in a research report on Wednesday, July 9th. Jefferies Financial Group lowered their price objective on Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. UBS Group lowered their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a research report on Thursday, July 17th. Finally, JPMorgan Chase & Co. lowered their price objective on Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a research report on Friday. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, Clorox has an average rating of "Hold" and a consensus price target of $144.83.

Insiders Place Their Bets

In other news, Director Pierre R. Breber purchased 4,000 shares of Clorox stock in a transaction that occurred on Wednesday, May 7th. The shares were bought at an average cost of $136.57 per share, with a total value of $546,280.00. Following the completion of the purchase, the director directly owned 4,000 shares in the company, valued at approximately $546,280. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.57% of the stock is currently owned by insiders.

Clorox Price Performance

Shares of Clorox stock opened at $130.80 on Friday. The company has a quick ratio of 0.44, a current ratio of 0.74 and a debt-to-equity ratio of 13.07. The company has a market cap of $16.12 billion, a PE ratio of 23.48, a P/E/G ratio of 3.44 and a beta of 0.51. The business has a 50 day moving average of $126.77 and a 200 day moving average of $140.15. The Clorox Company has a 52 week low of $117.35 and a 52 week high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a net margin of 9.89% and a return on equity of 324.23%. Clorox's revenue was down 8.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.71 EPS. As a group, equities research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.